Edgewise Therapeutics, Inc. (EWTX) Tops Q2 EPS by 8c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q2 EPS of ($0.34), $0.08 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• SEACOR Marine acknowledges letter from shareholder Pointillist
• Morgan Stanley Downgrades BioMerieux (BIM:FP) (BMXMF) to Underweight